| OAB0405 | Re-evaluating risk: evaluating opioid-related harm associated with stimulant use in people with chronic pain living with and without HIV | Oral abstract session with live Q&A | Co-morbidities |
| EPE0885 | Cost-effectiveness of treating anal pre-cancerous lesions among gay, bisexual and other men who have sex with men living with HIV | E-poster | Costing, cost effectiveness and affordability |
| EPE0886 | Cost-effectiveness of three different Pre-Exposure Prophylaxis (PrEP) regimens for HIV prevention in Mexico | E-poster | Costing, cost effectiveness and affordability |
| EPE0887 | Understanding the cost of pharmacy-delivered HIV pre- and post-exposure prophylaxis services in Kenya: findings from a pilot study | E-poster | Costing, cost effectiveness and affordability |
| EPE0888 | Cost-effectiveness of antiretroviral therapy adherence interventions in people living with HIV/AIDS: a systematic review of decision analytical models | E-poster | Costing, cost effectiveness and affordability |
| EPE0889 | Cost-effectiveness of dolutegravir compared with efavirenz for prevention of perinatal transmission in women presenting with HIV in late pregnancy in Uganda | E-poster | Costing, cost effectiveness and affordability |
| EPE0890 | Analysis on the costing the adoption of Kenya’s HIV test and treat guidelines, and its implication on the economic growth | E-poster | Costing, cost effectiveness and affordability |
| EPE0891 | Economic evaluation of HIV infection recency at four health facilities in Bangkok, Thailand | E-poster | Costing, cost effectiveness and affordability |
| EPE0892 | Optimal use of PrEP to reduce HIV incidence by 90% by 2030 in a low incidence setting | E-poster | Costing, cost effectiveness and affordability |
| EPE0893 | Impact of price subsidy strategy in promoting uptake of HIV self-testing kits in Abuja, Nigeria: a pilot implementation | E-poster | Costing, cost effectiveness and affordability |